mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.002 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.004 |